|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 108.90 USD | -1.54% |
|
+3.09% | +37.58% |
| Jul. 21 | CVS Health Releases Pet Medication in 9,000 Pharmacies | DJ |
| Jul. 17 | CVS Health Opens Pharmacy-Focused Location in Houston | MT |
| Market Cap | 141B 124B 115B 105B 199B 13,617B 202B 1,367B 535B 6,663B 530B 518B 23,018B | P/E 2026 * |
17.6x | P/E 2027 * | 15.3x |
|---|---|---|---|---|---|
| Enterprise Value | 197B 173B 160B 147B 277B 19,003B 281B 1,908B 747B 9,298B 739B 723B 32,121B | EV / Sales 2026 * |
0.48x | EV / Sales 2027 * | 0.45x |
| Free-Float |
71.2% | Yield 2026 * |
2.4% | Yield 2027 * | 2.48% |
Last Transcript: CVS Health Corporation
| 1 day | -1.20% | ||
| 1 week | +3.42% | ||
| Current month | +5.88% | ||
| 1 month | +8.12% | ||
| 3 months | +43.31% | ||
| 6 months | +32.47% | ||
| Current year | +38.02% |
| 1 week | 105.68 |  | 110.68 |
| 1 month | 99.81 | | 110.68 |
| Current year | 69.51 | | 110.68 |
| 1 year | 58.5 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
Ali Keshavarz
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/26/26 | Tax | Controller/Auditor | -454 | 0.0000% | ||
| 5/31/26 | Tax | Chief Technology Officer | -7,618 | 0.0006% | ||
| 5/31/26 | Tax | Chief Financial Officer | -2,478 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.14% | +3.42% | +79.32% | +44.21% | 141B | |
| +0.24% | -1.39% | +6.44% | +31.00% | 82.77B | |
| -0.98% | +4.31% | +4.43% | +55.61% | 28.27B | |
| +0.51% | +3.05% | +16.65% | +44.37% | 22.9B | |
| -1.12% | -0.89% | -16.55% | -30.12% | 20.02B | |
| +0.22% | +2.40% | +26.28% | +156.15% | 16.93B | |
| +0.59% | -5.22% | +4.31% | -4.96% | 14.68B | |
| -1.31% | +1.45% | +60.88% | +130.14% | 15.23B | |
| -1.25% | +1.47% | -6.25% | -12.04% | 13.12B | |
| -1.70% | -0.93% | -11.25% | +79.54% | 11.12B | |
| Average | -0.60% | +2.07% | +16.43% | +49.39% | 36.61B | |
| Weighted average by Cap. | -0.65% | +3.06% | +35.86% | +43.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 409B 359B 333B 306B 577B 39,506B 585B 3,967B 1,553B 19,331B 1,537B 1,504B 66,778B | 427B 374B 347B 319B 601B 41,174B 610B 4,135B 1,618B 20,147B 1,602B 1,567B 69,599B |
| Net income | 8.04B 7.05B 6.54B 6.01B 11.33B 776B 11.5B 77.96B 30.51B 380B 30.2B 29.55B 1,312B | 9.35B 8.19B 7.6B 6.99B 13.16B 902B 13.36B 90.57B 35.45B 441B 35.08B 34.33B 1,524B |
| Net Debt | 55.81B 48.9B 45.4B 41.72B 78.61B 5,385B 79.76B 541B 212B 2,635B 210B 205B 9,103B | 52.23B 45.76B 42.48B 39.04B 73.56B 5,040B 74.65B 506B 198B 2,466B 196B 192B 8,519B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-22 | $109.23 | -1.24% | 2,407,697 |
| 26-07-21 | $110.60 | +2.78% | 9,856,298 |
| 26-07-20 | $107.61 | +0.13% | 6,628,846 |
| 26-07-17 | $107.47 | +0.91% | 6,608,659 |
| 26-07-16 | $106.50 | +0.56% | 12,025,143 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
